ITCI: Intra-Cellular Sotuvga nisbatan narx
Atrof-muhitni muhofaza qilish uchun "yashil kimyo" tamoyillarining joriy etilishi Intra-Cellular Therapies (ITCI) uchun laboratoriya chiqindilarini yo'q qilish standartlariga asosiy rioya qilish bilan to'ldirilgan. GURU.Markets grafigidagi P/S koeffitsiyenti tarixi ushbu jarayonni vizuallashtiradi, bunda 20.60 joriy metrika darajasi vazifasini bajaradi. Biznes barqarorligi xalqaro biokomponentlar logistikasi va tadqiqot markazlarining diversifikatsiyasi bilan qo'llab-quvvatlanadi, bu esa kompaniya uchun yuqori uzoq muddatli daromadlilikni ta'minlaydi.
Intra-Cellular Therapies (ITCI) kompaniyasi koʻrsatkichlari kesimi va tahlili
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Intra-Cellular Therapies|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati intracellulartherapies.com|ITCI - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Intra-Cellular|ITCI - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Intra-Cellular Therapies|Oraliq qoplash koeffitsiyenti intracellulartherapies.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
ITCI - Sof daromad|Kelajakdagi sof foyda Intra-Cellular Therapies|ITCI - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori intracellulartherapies.com|ITCI - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Intra-Cellular|ITCI - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Intra-Cellular Therapies|ITCI - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi intracellulartherapies.com|ITCI - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi Intra-Cellular Therapies
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:ITCI Intra-Cellular Therapies Inc.
P/S koeffitsienti bozor kapitalizatsiyasini savdo hajmi bilan bog'laydi va biznesning kelajakdagi sektor ulushiga oid investorlar kutganlarini aks ettiradi. P/S koeffitsiyentining tarixiy o'rtacha qiymatidan chetlashishini tahlil qilish aktivlarning haddan tashqari qimmat baholanganini aniqlash imkonini beradi, bu esa Intra-Cellular Therapies (ITCI) uchun juda muhimdir, chunki u yerda aksiyalarning yuqori narxi ulkan R&D xarajatlari va neyrobiologiya sohasida yetakchilik qilish imkoniyati bilan asoslanadi.
Intra-Cellular Therapies raqobatchilari
Kapitalizatsiyaning daromadga nisbati biogen.com BIIB|P/S multiplikatori NBIX (Neurocrine Biosciences, Inc.)|Regencell Bioscience Ltd (RGC) - Sotuvga nisbatan narx|AXSM - Narxning daromadga nisbati|ACAD: Narxning daromadga nisbati|Xenon Pharmaceuticals (XENE) - Narxning daromadga nisbati|VKTX (vikingtherapeutics.com) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati SUPN|P/S multiplikatori Catalyst Pharma|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|Narxning daromadga nisbati HRMY (Harmony Corp)|P/S multiplikatori BHVN (Biohaven Ltd.)|P/S multiplikatori amylyx.com AMLX|TRVI - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PRAX (Praxis Precision Medicines Inc)|AVXL (Anavex Corp) - Kapitalizatsiyaning daromadga nisbati|CeriBell EEG - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PRTA|ALEC (Alector Therapeutics) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori ANNX|OMER (omeros.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NGNE (Neurogene Corp)|AC Immune Inc (ACIU) - Sotuvga nisbatan narx|VYGR - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati NMRA (neumoratx.com)|SCLX: P/S multiplikatori|Tevogen Bio Holdings Inc. (TVGN) - P/S multiplikatori|Narxning daromadga nisbati Alpha Cognition Inc|Cognition Therapeutics Inc. - Narxning sotuvga nisbati|P/S multiplikatori IKT|Narx/daromad koeffitsiyenti cassavasciences.com|P/S multiplikatori ASRT (Assertio)|Coya Therapeutics Inc (COYA) - Sotuvga nisbatan narx|VTGN - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Ovid Therapeutics Inc. OVID|ABOS: P/S multiplikatori|CRVO - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati ATHE|CLNN (Clene Nanomedicine) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori PEPG|Kapitalizatsiyaning daromadga nisbati Jupiter Neurosciences, Inc. JUNS|P/S multiplikatori RLMD (Relmada Therapeutics)|Narx/daromad koeffitsiyenti annovisbio.com (ANVS)|GRCE - Narxning daromadga nisbati|AIFF (Firefly Neuroscience, Inc.) - Kapitalizatsiya va daromad nisbati|KLTO: P/S multiplikatori|Sotuvga nisbatan narx NeuroSense Therapeutics Ltd. (NRSN)|Kapitalizatsiyaning daromadga nisbati RVPH|P/S multiplikatori MetaVia, Inc.|Narxning daromadga nisbati NeurAxis (NRXS)|HSDT (heliusmedical.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Passage Bio PASG|Neuphoria Therapeutics, Inc. (NEUP) - Sotuvga nisbatan narx|Minerva Neurosciences - P/S multiplikatori|Narx/daromad koeffitsiyenti athira.com ATHA|Addex Therapeutics Ltd (ADXN) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati ALZN|Kapitalizatsiyaning daromadga nisbati CYCN|PTIX (Protagenic) - Kapitalizatsiyaning sotish hajmiga nisbati|Narxning daromadga nisbati Pasithea Therapeutics (KTTA)|CRGT (cortigent.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ATXI (Avenue Therapeutics, Inc.)|P/S multiplikatori Brainstorm Cell Therapeutics Inc. BCLI|CARA: Kapitalizatsiyaning daromadga nisbati|Narx/daromad multiplikatori Chromocell (CHRO)|ELYM: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati longboardpharma.com|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|Sotuvga nisbatan narx NKGen Biotech Inc NKGN|Narxning daromadga nisbati NeuroBo (NRBO)|Narxning daromadga nisbati SAGE (Sage Therapeutics Inc)|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|trevena.com - Narxning daromadga nisbati|VIGL: Kapitalizatsiyaning daromadga nisbati|WENA - P/S multiplikatori|Cerevel (CERE) - Narxning daromadga nisbati
